NurseJet
Back to Discover
Research ArticleResearchPatient Education

Integrated exposure therapy reduced PTSD symptoms faster in young people with substance use

European journal of psychotraumatology (PubMed)Jul 21, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

In a randomized trial of 55 participants age 12 to 25 with co-occurring post-traumatic stress and substance use disorders, integrated exposure-based COPE-A produced greater and faster improvement in PTSD outcomes than person-centered supportive therapy.

What NurseJet pulled from the source

At four months, COPE-A produced a 9.82-point greater reduction in PTSD symptom severity and lower odds of meeting PTSD diagnostic criteria than the comparison therapy; improvements were maintained through 12 months. Both groups reduced substance use and disorder severity over time, with no significant between-group difference. Participants reported greater satisfaction with COPE-A, and no study-related adverse events were reported.

Why this matters for nurses

Mental-health nurses often care for young people whose trauma symptoms and substance use interact, complicating engagement and treatment planning. The trial supports coordinated treatment rather than requiring PTSD work to wait for substance-use remission, while leaving exposure therapy to appropriately trained clinicians.

Bedside takeaway

Integrated therapy accelerated PTSD improvement, while substance-use outcomes were similar and treatment still requires trained clinical oversight.

How This Applies in Practice

Use this when: Caring for an adolescent or young adult receiving clinician-directed treatment for co-occurring PTSD and substance use disorder.

On your shift

  • Assess trauma symptoms, substance use, acute safety, and barriers to engagement as related but distinct parts of the care plan.
  • Reinforce the therapist's coping and attendance plan and document symptom, substance-use, or safety changes between sessions.
  • Communicate worsening distress, intoxication or withdrawal concerns, self-harm risk, or disengagement to the responsible mental-health team.
Keep in mind: Do not initiate or conduct exposure therapy without the required training and treatment structure. Follow the mental-health protocol, facility policy, and patient-specific provider orders.

Explain this for my unit

Key takeaways

  • The trial randomized 55 adolescents and young adults age 12 to 25 to COPE-A or person-centered supportive therapy.
  • COPE-A produced a greater reduction in PTSD symptoms by the four-month primary endpoint.
  • Substance-use outcomes improved over time in both groups without a significant between-group difference.
  • The small single-region trial reported no study-related adverse events but cannot establish safety or effectiveness across all youth settings.

Practice implications

  • Assess and document trauma symptoms, substance use, acute risk, engagement barriers, and treatment goals without framing one condition as a reason to ignore the other. Support attendance and coping plans, monitor response and safety, and communicate changes to the clinician delivering the integrated therapy.

Limitations & cautions

  • The trial enrolled 55 participants in Sydney, most of whom were female, and compared two active psychotherapies. The small sample limits subgroup and uncommon-harm assessment, substance-use outcomes did not differ between groups, and results may not generalize to other ages, settings, treatment models, or levels of acuity.
  • AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

European journal of psychotraumatology (PubMed)

European journal of psychotraumatology (PubMed). Integrated exposure-based therapy for co-occurring post-traumatic stress and substance use among young people: a randomized controlled trial.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42478200/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Frontiers in psychiatry (PubMed)Practice applicable

A systematic review and meta-analysis of 14 observational studies involving 12,920 people found limited long-term stability after an initial diagnosis of acute and transient psychotic disorder, with diagnostic change and relapse common during follow-up.

PsychAI summaryReview source

Advances in neonatal care : official journal of the National Association of Neonatal Nurses (PubMed)Practice applicable

In 183 paired COMFORTneo assessments, overall agreement was excellent, but interrater reliability increased from 0.41 at 24 to 26 weeks' gestation to 0.92 at 36 weeks or later, indicating less consistent scoring in extremely preterm infants.

PedsICUAI summaryReview source

European journal of pediatrics (PubMed)Practice applicable

In a randomized crossover trial of intra-articular injections for juvenile idiopathic arthritis, intranasal dexmedetomidine and inhaled nitrous oxide produced similarly mild immediate patient-reported pain, while recalled pain was lower with nitrous oxide and 69% preferred it for future sedation.

PedsMed-SurgAI summaryReview source